You are here:

esomeprazole IV 40mg powder (Nexium)

Advice

Following a full submission

esomeprazole (Nexium I.V.®) is accepted for use within NHS Scotland for prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.

In patients with high-risk peptic ulcer bleeding, high-dose intravenous esomeprazole significantly reduced recurrent bleeding at 72 hours compared to placebo.

Drug Details

Drug Name: esomeprazole IV 40mg powder (Nexium)
SMC Drug ID: 578/09
Manufacturer: AstraZeneca UK Ltd
Indication: Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.
BNF Category:
Submission Type: Full submission
Status: Accepted
Date Advice Published: 9 November 2009

Back